Similar to the chemotherapeutic agents mentioned above, none of the 28 natural compounds (Figure 2) we have mentioned in this article have been shown to be agonists of DR5; they all promote apoptosis in prostate cancer cells by increasing the expression of DR5 protein. Here, TNFRSF10B is linked to prostate carcinoma.